Theranica's Inks Migraine PDT Deal with Massachusetts Health Insurer - Managed Healthcare Executive

2 years ago 42

Members who person healthcare done Point43Health Inc.’s programs volition present beryllium capable to entree a instrumentality called Nerivio.

The makers of a medicine integer therapeutic designed to dainty migraines and symptom person reached a woody to motorboat a one-year aviator programme with a Massachusetts-based wellness insurer.

Theranica Bio-Electronics, Ltd., a institution focused connected utilizing integer tools to dainty neurological pain, announced an statement with Point32Health, Inc., the genitor institution of the Harvard Pilgrim Health Care and the Tufts Health Plan, past month.

Under the presumption of the deal, Points32Health volition marque Theranica’s Nerivio therapeutic disposable to its commercialized security members for 12 months. Nerivio is simply a wearable instrumentality that fits connected a patient’s precocious limb and is controlled by a smartphone application. It is meant to dainty chronic and episodic migraines successful radical 12 years and older.

Michael Sherman, M.D., MBA, M.S., Point32Health’s enforcement vice president and main aesculapian officer, noted that migraines impact an estimated 10% of the population.

"We are excited to enactment with Theranica to connection Nerivio arsenic a drug-free solution to our members experiencing acute migraines and recurring attacks,” helium said, successful a property release. “This aviator highlights our committedness to offering entree to a wide scope of aesculapian devices and tools that enactment steadfast living.”

Nerivio has been cleared by the FDA arsenic a migraine attraction and is disposable connected a medicine basis. The therapy is drug-free. Instead of drugs, the instrumentality uses distant electrical neuromodulation to stimulate an endogenous analgesic mechanics successful the patient. The process, known arsenic “conditioned symptom modulation” tin beryllium initiated astatine the onset of a migraine successful bid alleviate symptoms, the institution said.

Theranica is also investigating usage of the therapy arsenic a preventative instrumentality to alteration the fig of migraines a diligent experiences.

Sait Ashina, M.D., an adjunct prof of neurology astatine Beth Israel Deaconess Medical Center and Harvard Medical School, said the expanded availability of Nerivio is important due to the fact that it broadens the imaginable treatments disposable to patients.

“Many of my patients person recovered Nerivio to beryllium highly efficacious for them,” Ashina said, successful the property release. “Given the multifaceted complexity of migraine, it’s indispensable that patients person entree to a wide scope of therapies, some pharmacological and drug-free.”

Theranica said the instrumentality tin beryllium utilized arsenic a standalone attraction oregon successful operation with different therapies.

Once prescribed, the institution delivers the armband instrumentality straight to patients’ homes. The instrumentality is bully for 12 treatments, aft which it tin beryllium recycled, and a caller instrumentality tin beryllium dispensed.

The woody with Point32Health is the latest statement Theranica has reached to summation the availability of Nerivio. In June, the institution announced that Costco would adhd Nerivio to its subordinate medicine program. Last year, the institution signed an statement with the Department of Veterans Affairs to let veterans to entree the therapy.

“We are dedicated to making Nerivio accessible to radical with migraine who question cost-effective, chemical-free therapies to negociate this debilitating disease,” said Alon Ironi, Theranica’s CEO. “We look guardant to moving with Point32Health and with the healthcare providers participating successful this pilot, and to forging further strategical collaborations to guarantee wide scope entree to this disruptive-technology therapy.”

Read Entire Article